P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Running, not enrolling · Not applicable

Conditions studied: Degenerative Disc Disease

In brief

The aim of this trial is to evaluate if P-15L bone graft (investigational device) is not inferior in effectiveness and safety to local autologous bone (and allograft where necessary) as an extender (control device) when applied in instrumented transforaminal lumbar interbody fusion (TLIF) in subjects with degenerative disc disease (DDD). In addition to the general overall objective, a sub-group analysis will be performed on the high-risk subject population (tobacco use, obesity, diabetes), as previous studies have shown negative effects of smoking, obesity and diabetes on fusion and bone healing, increased peri/postoperative complications, and lower patient-reported outcome scores.

Key facts

Study ID
NCT03438747
Run by
CeraPedics, Inc
People needed
290
Starts
2018-04-24
Expected to finish
2028-02-28
Last updated by the study team
2025-10-06

Who can join

Age: 22 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.